iCAD and Fischer Imaging sign agreement to provide computer aided detection capabilities
iCAD Inc, which designs, develops and markets Computer Aided Detection (CAD) imaging technology and systems for the early detection of breast cancer, and Fischer Imaging Corporation, a technological leader in the manufacturing and marketing of digital mammography and medical imaging systems, have entered into a development and marketing agreement to provide computer aided detection capabilities for the Fischer SenoScan TrueView digital mammography system.Under the agreement, the companies will cooperate in adapting iCAD's computer aided detection technology for use in analysis of digital mammograms created by the Fischer system, assisting radiologists in identifying cancers that might otherwise be overlooked in routine mammography screening.
The Agreement formalizes ongoing cooperation between the companies, and was announced at the annual Radiological Society of North America (RSNA) Exposition in Chicago, where iCAD and Fischer demonstrated the iCAD system operating with Fischer digital images, and displaying iCAD results on the Fischer Digital Mammography system display.The companies will cooperate in securing FDA approval for the combination of iCAD's software and Fischer's SenoScan digital mammography system, which is required for clinical use in the United States.
Under the Agreement, Fischer Imaging will have worldwide exclusive rights to market this specialized iCAD software together with Fischer's digital mammography system.According to Gerald D. Knudson, Fischer Imaging's Chief Executive Officer, "At Fischer Imaging we have made a full commitment to focus our efforts on women's healthcare, and in particular, the early detection of breast cancer.In bringing together our SenoScan TrueView Digital Mammography and iCAD's technology for computer aided detection of breast cancer, we continue to offer the very best in breast imaging and diagnostic technology.The SenoScan's industry leading resolution of 50 microns in screening mode and 25 microns in diagnostic mode make it the ideal platform for iCad's technology.We look forward to the results of this collaborative effort."
"Digital mammography and computer aided detection are obvious and essential partners in early detection of breast cancer," said Scott Parr, iCAD's CEO."We are pleased and excited to be working with Fischer Imaging, a company which has already demonstrated a creative and effective approach to digital mammography."